Abstract: In an embodiment, the present invention provides a compound of the formula: or a pharmaceutically acceptable salt thereof, and methods of using this compound for treating type II diabetes mellitus.
| # | Name | Date |
|---|---|---|
| 1 | 202317078353-STATEMENT OF UNDERTAKING (FORM 3) [17-11-2023(online)].pdf | 2023-11-17 |
| 2 | 202317078353-PRIORITY DOCUMENTS [17-11-2023(online)].pdf | 2023-11-17 |
| 3 | 202317078353-POWER OF AUTHORITY [17-11-2023(online)].pdf | 2023-11-17 |
| 4 | 202317078353-FORM 1 [17-11-2023(online)].pdf | 2023-11-17 |
| 5 | 202317078353-DECLARATION OF INVENTORSHIP (FORM 5) [17-11-2023(online)].pdf | 2023-11-17 |
| 6 | 202317078353-COMPLETE SPECIFICATION [17-11-2023(online)].pdf | 2023-11-17 |
| 7 | 202317078353-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [17-11-2023(online)].pdf | 2023-11-17 |
| 8 | 202317078353-MARKED COPIES OF AMENDEMENTS [30-12-2023(online)].pdf | 2023-12-30 |
| 9 | 202317078353-FORM 18 [30-12-2023(online)].pdf | 2023-12-30 |
| 10 | 202317078353-FORM 13 [30-12-2023(online)].pdf | 2023-12-30 |
| 11 | 202317078353-AMMENDED DOCUMENTS [30-12-2023(online)].pdf | 2023-12-30 |
| 12 | 202317078353-Proof of Right [17-01-2024(online)].pdf | 2024-01-17 |
| 13 | 202317078353-FORM 3 [16-05-2024(online)].pdf | 2024-05-16 |